Myopia, or nearsightedness, is an epidemic in large parts of the world. What was a small nuisance readily treated by glasses or contact lenses, myopia has quietly entered the medical arena as an epidemic. Predictions now expect that as much as half of all human beings on the planet will be nearsighted by 2050. The plague, especially among children and youths, is attributed to environmental factors such as increased use of computers and other screens and reduced playing time outside.
And as myopia becomes more widespread, so does the greater demand to create greater, longer-term solutions to address it. And thank goodness, a brighter and warmer tomorrow awaits for treating myopia by miracles of technology, medicine, and life change. So then let us look back in the past, and look ahead into the future, of managing myopia.
Understanding the Myopia Crisis
The mild myopia is harmless but progressive myopia or high myopia can produce catastrophic sequelae of macular degeneration, glaucoma, retinal detachment, and blindness. The myopic children who develop myopia at an early age are most vulnerable to such end-stage sequelae.
Current Treatment Landscape
Previously, myopia has been controlled almost entirely by means of refractive correction—contact lenses or eyeglasses—to enhance vision. Long-term effects in adults are from refractive surgery such as LASIK but no measures to avert development of myopia in children.
Prevention or even the reversal of myopia has been the question of the times, rather than just correcting one's vision. Today's technology ranges from orthokeratology (ortho-k) to prescribed multifocal contact lenses and atropine eye drops, the latter which has achieved such gigantic promising outcomes.
Read Also: Why Sitting Too Long Is Harmful
Horizon Innovations
- Pharmaceutical Development
Low dose atropine eye drops would be the most evidence-based pharmacologic treatment to date for the slowing of myopia progression. Very widely used routinely in Asia, elsewhere adoption has been experienced with additional further higher longer term safety and efficacy studies. Side effect reduced second generation atropine and improved drug delivery technology in the pipeline.
Apart from atropine, scientists are looking for other drugs that have the potential to impact eye development and growth and result in more accurate and safer long-term therapies.
- Intelligent Contact Lenses and Glasses
Biologists and technology companies are inventing "intelligent" glasses that, apart from aligning human eyes directly, do a lot more. Future glasses will prevent myopia ahead of time by re-focusing length or even on real-time vision issue adjustment needs.
It is also accompanied by internally integrated smart glasses with in-board light sensors or emitting constant wavelengths of light, these having been researched as a method for stimulating eye development and inhibiting the progression of myopia. These have less invasive and higher tolerance than existing treatment.
- Gene Therapy and Regenerative Medicine
While still in the trial stage, gene therapy would be in the near future soon the driving force behind sustained cure by genetic mechanism of regulation of eye growth. Stem cell technology may be applied to replacement or reconstitution of retinal tissue in severe myopia.
While a few years ahead of current practice, these are a superb promising area of personalized eye care.
- Artificial Intelligence and Predictive Analytics
AI is seeping into the medical space, and ophthalmology is no exception. It is increasingly likely that machine learning algorithms are able to establish which children have the highest likelihood of being at risk for developing progressive myopia according to genetics, way of life, and biometric status.
Early diagnosis is early treatment, most important to successful management of myopia. Wearable or smartphone technology is an imaginable future wear tracking a child's eye movements and warning parents or physicians to impending threat.
Lifestyle Interventions: The First Line of Defense
Modifying lifestyle is the best advocate of the prevention and control of myopia to as large an extent as it has the application of hi-tech technology. In some research, more time spent outdoors—at least two hours a day—has lowered risk for children to become myopic.
Parents and teachers are finally on to this, and school systems are beginning to incorporate outdoor time into core curricula and introduce digital detoxing. The future can look forward to public health campaigns for "visual hygiene" as we now campaign for tooth hygiene or hand washing.
An Integrated Approach
The future of myopia treatment is not this individual success but one single, tailored solution combining prevention, early treatment, and high-tech therapy. Eyecare practitioners are shifting practice to prevention system—tracking progress over time, changing and monitoring schedules as appropriate, and engaging kids and parents.
International collaboration among scientists, physicians, and biotech companies is the imperative. Researchers are increasingly cooperating with regulators to introduce new, new medicines onto the market in innovative way.
Conclusion: A Better Vision World
The war against the epidemic of myopia continues to be unfought, yet we are hopeful. With what we are doing in pharmacology, wearable technology, artificial intelligence, and education on lifestyle industries, we are where myopia is not only curable but also preventable.
And with miracles on the agenda and news continuing to break, the vision of a less myopic world with less of humanity dazed by myopia—and its ghastly consequences—still comes into focus.